---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-005752"
form_type: "8-K"
ticker: "SMTI"
cik: "0000714256"
company_name: "Sanara MedTech Inc."
filed_at: "2023-02-22T23:59:59+00:00"
generated_at: "2026-06-19T05:42:30.413862+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Sanara MedTech Q4 revenue jumps 119% YoY to $15.3M; full-year revenue up 90% to $45.8M

## Summary
- Net revenue $15.3M in Q4 2022 (up 119% from $7.0M); full-year $45.8M (up 90% from $24.1M).
- Operating loss expected $2.0M-$3.5M in Q4 vs $3.4M loss prior year; full-year loss $11.0M-$12.5M vs $7.4M.
- Cash and equivalents $9.0M as of December 31, 2022.
- Recorded non-cash loss on dissolution of Sanara Pulsar of $1.0M in Q4.

## SEC filing metadata
- accession: 0001493152-23-005752
- form_type: 8-K
- ticker: SMTI
- cik: 0000714256
- company_name: Sanara MedTech Inc.
- filed_at: 2023-02-22T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/714256/000149315223005752/0001493152-23-005752-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/714256/000149315223005752/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-005752
- JSON: https://secwatch.observer/filing/0001493152-23-005752.json
- Plain text: https://secwatch.observer/filing/0001493152-23-005752.txt

## Key facts
- Earnings Releases
  Sanara MedTech Inc. reported the fourth quarter and full year 2022 results: revenue approximately $15.3 million.
  - Period: the fourth quarter and full year 2022
  - Revenue: approximately $15.3 million
  - Result: preliminary results
  source text: preliminary results for the fourth quarter and full-year 2022. Selected Fourth Quarter and Full-Year 2022 Preliminary Results (Unaudited) ● Net revenue of approximately $15.3 million for the three months ended December 31, 2022, compared to net revenue of $7.0 million for the three months ended December 31, 2021, which would result in a record net revenue
  evidence_url: https://www.sec.gov/Archives/edgar/data/714256/000149315223005752/0001493152-23-005752-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.